1 Ocak 2016 Dergi makalesi Açık Erişim

Oner, Ebru Toksoy; Hernandez, Lazar; Combie, Joan

MARC21 XML

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Hernandez, Lazar</subfield>
    <subfield code="u">Enzyme Technol Grp, Ctr Genet Engn &amp; Biotechnol CIGB, Ave 31 E-150 &amp; 190,POB 6162, Havana 10600, Cuba</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Combie, Joan</subfield>
    <subfield code="u">Montana Biopolymers Inc, 119 Cathcart Circle, Winnsboro, SC 29180 USA</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="4">
    <subfield code="p">BIOTECHNOLOGY ADVANCES</subfield>
    <subfield code="v">34</subfield>
    <subfield code="n">5</subfield>
    <subfield code="c">827-844</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="a">Creative Commons Attribution</subfield>
    <subfield code="u">http://www.opendefinition.org/licenses/cc-by</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.1016/j.biotechadv.2016.05.002</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Review of Levan polysaccharide: From a century of past experiences to future prospects</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Oner, Ebru Toksoy</subfield>
    <subfield code="u">Marmara Univ, Dept Bioengn, IBSB, Istanbul, Turkey</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="o">oai:zenodo.org:111600</subfield>
    <subfield code="p">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="2">opendefinition.org</subfield>
    <subfield code="a">cc-by</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2016-01-01</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="u">https://aperta.ulakbim.gov.trrecord/111600/files/bib-69bce684-96c6-4ed0-b494-610330a75b0e.txt</subfield>
    <subfield code="z">md5:98f3e98df5286d44a1baa7c7218958c3</subfield>
    <subfield code="s">172</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <controlfield tag="005">20210420142243.0</controlfield>
  <controlfield tag="001">111600</controlfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Levan is a fascinating beta-(2,6)-linked fructose polymer with an unusual,combination of properties characterized in this review. In nature, levan is synthesized from sucrose by a wide range of microorganisms and a few plant species. Bacterial levans often have molecular weights over 500,000 Da, are commonly branched, and form compact nanospheres offering a broad spectrum of applications. The most relevant genetic, biochemical and structural aspects of the biosynthetic enzyme levansucrase are detailed. Optimization of parameters for levan production by intact bacteria and by the isolated enzyme is surveyed. The diversity of current and potential applications of levan is illustrated by a discussion of uses ranging from personal care and aquaculture to the medical and food industries. (C) 2016 Elsevier Inc. All rights reserved.</subfield>
  </datafield>
</record>